Natural product-based Neuron replacement therapy for Neurodegenerative diseases: Withaferin A (WFA) promotes neuronal cell conversion from differentiated cells via up regulation of its target gene, 2/February/2015, 23.28

Natural product-based Neuron replacement therapy for Neurodegenerative diseases: Withaferin A (WFA) promotes neuronal cell conversion from differentiated cells via up regulation of its target gene, 2/February/2015, 23.28

Natural product-based Neuron replacement therapy for Neurodegenerative diseases: Withaferin A (WFA) promotes neuronal cell conversion from differentiated cells via up regulation of its target gene, 2/February/2015, 23.28 150 150 Dr Boomi's Genom-2-Discovery Center

Idea Proposed/Formulated byDr L Boominathan Ph.D.

Web: http://genomediscovery.org

Significance: This study suggests that Withaferin A, by increasing the expression of its target gene, it may convert the differentiated cells into Neuronal cells. Together, pharmacological formulations encompassing “Withaferin A or its analogues may be used in the treatment of Neurodegenerative diseases.

Amount: $ 500*

Undisclosed information: How Withaferin A  promotes neuronal conversion from differentiated cells

Terms & Conditions apply http://genomediscovery.org/registration/terms-and-conditions/

To citeBoominathan:  Natural product-based Neuron replacement therapy for Neurodegenerative diseases: Withaferin A (WFA) promotes neuronal cell conversion from differentiated cells via up regulation of its target gene, 2/February/2015,  23.29,  Genome-2-Bio-Medicine Discovery center (GBMD), http://genomediscovery.org

Courtesy: When you cite drop us a line at info@genomediscovery.org

* Research cooperation